Claus Röedel

694 total citations
28 papers, 241 citations indexed

About

Claus Röedel is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claus Röedel has authored 28 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claus Röedel's work include Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). Claus Röedel is often cited by papers focused on Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). Claus Röedel collaborates with scholars based in Germany, United States and Switzerland. Claus Röedel's co-authors include Rolf Sauer, Ch. Wittekind, Rainer Fietkau, Peter Martus, Werner Hohenberger, Vincenzo Valentini, R. Raab, Rainer Fietkau, Gerhard G. Grabenbauer and Bruce D. Minsky and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Claus Röedel

28 papers receiving 235 citations

Peers

Countries citing papers authored by Claus Röedel

Since Specialization

Citations

This map shows the geographic impact of Claus Röedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Röedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Röedel more than expected).

Fields of papers citing papers by Claus Röedel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus Röedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Röedel. The network helps show where Claus Röedel may publish in the future.

Co-authorship network of co-authors of Claus Röedel

This figure shows the co-authorship network connecting the top 25 collaborators of Claus Röedel. A scholar is included among the top collaborators of Claus Röedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus Röedel. Claus Röedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy 2022 ·British Journal of Cancer ·Georg Emons, Noam Auslander, Peter Jo, Julia Kitz, Azadeh Azizian, Yue Hu, Clemens F. Hess, Claus Röedel, Ulrich Sax, Gabriela Salinas, Philipp Stroebel, Frank Krämer, Tim Beißbarth, Marian Grade, Michael Ghadimi, Eytan Ruppin, Thomas Ried, Jochen Gaedcke	11
2	Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts. 2020 ·Journal of Clinical Oncology ·Elisa Fontana, Clizia Zichi, (unknown), Murielle Mauer, Claus Röedel, Emmanouil Fokas, Ralf‐Dieter Hofheinz, Dirk Arnold, Hans‐Joachim Schmoll, Eric Van Cutsem, Karin Haustermans, Alexander Stein, Jean‐Pierre Gérard, Thierry Conroy, Claire Jouffroy-Zeller, Markus Moehler, Florian Lordick, Irit Ben‐Aharon, Massimo Di Maïo, (unknown)	5
3	A multicenter phase II trial of the combination cisplatin/ docetaxel/durvalumab/tremelimumab as single-cycle induction treatment in locally advanced HNSCC (CheckRad-CD8 trial). 2020 ·Journal of Clinical Oncology ·Markus Hecht, Antoniu‐Oreste Gostian, Markus Eckstein, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias Hautmann, Thomas Brunner, Simon Laban, Günther Klautke, Bálint Tamaskovics, Axel Hinke, Benjamin Frey, Sabine Semrau, Arndt Hartmann, Claus Röedel, Wilfried Budach, Udo S. Gaipl, Heinrich Iro, Rainer Fietkau	2
4	The “RENAISSANCE” Trial: Effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction—A phase III trial of the German AIO/CAO-V/CAOGI. 2017 ·Journal of Clinical Oncology ·Daniel Mueller, Stefan Paul Moenig, Arndt Vogel, Sylvie Lorenzen, Nils Homann, Christoph Reißfelder, Claus Bolling, Wolfgang Blau, Wolff Schmiegel, Patrick Michl, Karel Caca, Matthias Schwarzbach, Ralf‐Dieter Hofheinz, Claus Röedel, Manish A. Shah, Mitsuru Sasako, Wolf O. Bechstein, Hauke Lang, Claudia Pauligk, Salah‐Eddin Al‐Batran	2
5	MRI-Based Treatment of Rectal Cancer: Is Prognostication of the Recurrence Risk Solid Enough to Render Radiation Redundant? 2013 ·Annals of Surgical Oncology ·Marie‐Luise Sautter‐Bihl, Werner Hohenberger, Rainer Fietkau, Claus Röedel, Heinz Schmidberger, Rolf Sauer	7
6	Local Recurrence and Survival for the German Centers in the TARGIT-A (TARGeted Intraoperative Radiation Therapy - Alone) Trial 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Frederik Wenz, Jayant S. Vaidya, Steffi Pigorsch, Petra Feyer, Claus Röedel, Claus Belka, Johannes Fleckenstein, M. Bremer, David Joseph, Michael Baum	2
7	Evaluation of response after chemoradiation for rectal cancer as a predictive factor for the benefit of adjuvant chemotherapy: A pooled analysis of 2,724 individual patients. 2011 ·Journal of Clinical Oncology ·Geerard L. Beets, Monique Maas, Patricia J. Nelemans, Vincenzo Valentini, Christopher H. Crane, Carlo Capirci, Claus Röedel, Li‐Jen Kuo, Julio García‐Aguilar, R. Glynne‐Jones	6
8	Preoperative chemoradiation (CRT) with concurrent capecitabine (Cap), oxaliplatin (Ox), and bevacizumab (Bev) in patients with locally advanced rectal cancer (RC): Effects on pathological complete response (pCR) and surgical complications. 2011 ·Journal of Clinical Oncology ·Thomas Hoehler, Kathrin Dellas, D. Riesenbeck, Thomas S. Reese, (unknown), Claus Röedel, W. Wagner, (unknown), (unknown), Jürgen Dunst	3
9	Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. 2011 ·Journal of Clinical Oncology ·Claus Röedel, Heinz Becker, Rainer Fietkau, Ullrich Graeven, Werner Hohenberger, Torsten Hothorn, Marga Lang-Welzenbach, Torsten Liersch, Ludger Staib, Hans Christiansen, Ch. Wittekind, Rolf Sauer, (unknown)	49
10	Combined Modality Therapy for Rectal Cancer 2010 ·The Cancer Journal ·Bruce D. Minsky, Claus Röedel, Vincenzo Valentini	14
11	Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in advanced rectal cancer. 2010 ·Journal of Clinical Oncology ·Daniel Vallböhmer, (unknown), Dongyun Yang, K. D. Danenberg, P. Danenberg, Dirk Arnold, J. H. Machiels, Claus Röedel, Vaneja Velenik, Heinz‐Josef Lenz	2
12	EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC). 2010 ·Journal of Clinical Oncology ·Kathrin Dellas, (unknown), Dirk Arnold, Matthias Kappler, Matthias Hipp, F Bataille, Dirk Vordermark, Claus Röedel, Anders Hartmann	1
13	Neoadjuvant Capecitabine Combined with Standard Radiotherapy in Patients with Locally Advanced Rectal Cancer 2008 ·Strahlentherapie und Onkologie ·Juergen Dunst, Jürgen Debus, Volker Rudat, Joern Wulf, Wilfried Budach, (unknown), Thomas S. Reese, Stephan Mose, Claus Röedel, (unknown), Axel Hinke	41
14	Organ Preserving, Quadrimodal Treatment of T1-2N0M0 Bladder Cancer: Results After Trans-urethral Resection and Simultaneous Radiochemotherapy Combined With Regional Deep Hyperthermia 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Michael Wittlinger, Claus Röedel, (unknown), Manfred Schmidt, Rolf Sauer, Oliver J. Ott	2
15	Prognostic factors after neoadjuvant radiochemotherapy for rectal cancer: Update of the CAO/ARO/AIO-94 Phase III study 2005 ·Journal of Clinical Oncology ·Rolf Sauer, Claus Röedel, Peter Martus, Rainer Fietkau, Ch. Wittekind	7
16	Tumor regression grading as prognostic factor in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Claus Röedel, Rainer Fietkau, R. Raab, Ch. Wittekind, Peter Martus, Rolf Sauer	8
17	Phase I/II trial of preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer 2003 ·International Journal of Radiation OncologyBiologyPhysics ·Claus Röedel, Gerhard G. Grabenbauer, Werner Hohenberger, Thomas Papadopoulos, Rolf Sauer	6
18	Supratentorial Low-Grade Glioma: Results and Prognostic Factors Following Postoperative Radiotherapy 2000 ·Strahlentherapie und Onkologie ·Gerhard G. Grabenbauer, Claus Röedel, Werner Paulus, Oliver Ganslandt, (unknown), Michael Buchfelder, (unknown), Rudolf Fahlbusch, W. Huk, Rolf Sauer	35
19	Lymphoedema, lymphatic microangiopathy and increased lymphatic and interstitial pressure in a patient with Parkinson's disease. 1999 ·PubMed ·Marc Husmann, Claus Röedel, Anders J. Leu, Renate Koppensteiner, Franzeck Uk	4
20	[Clinical value of a polymerase chain reaction on cytomegalovirus DNA in cerebrospinal fluid in HIV patients with neurological symptoms]. 1995 ·PubMed ·Claus Röedel, R. Grob, C. Ruef	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact